RICHMOND, Va. (WRIC) — According to the Centers for Disease Control and Prevention (CDC), Influenza B-positive tests have risen from 0.12% to 0.36% from January to the last week of March in the United ...

Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...

In July 2024, GSK assumed full control for the development, manufacturing and commercialization of influenza vaccines through new licensing agreement According to GSK, the data demonstrated positive ...

The cell-based flu vaccine was more effective than the egg-based vaccine in those aged 6 months to 64 years during the 2023-2024 flu season.

Lead formulations evaluated in the Phase 1/2 study demonstrated robust immune responses to influenza A, influenza B, and SARS-CoV-2 strains Safety profile of the mRNA-based combination vaccine ...

Phase 2 data demonstrated positive immune responses to A and B strains, with acceptable safety and reactogenicity profile, meeting all pre-defined study endpoints Vaccine candidate based on CureVac's ...